...
首页> 外文期刊>JAMA neurology >Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis
【24h】

Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis

机译:血浆置换术和静脉内免疫球蛋白作为青少年重症肌无力维持治疗的比较

获取原文
获取原文并翻译 | 示例
           

摘要

IMPORTANCE Juvenile myasthenia gravis (MG) is a relatively rare autoimmune disorder. The comparative efficacy of plasmapheresis (PLEX) vs immunoglobulin as maintenance therapy is unclear for this childhood disease. OBJECTIVE To determine whether PLEX or intravenous immunoglobulin (IVIG) therapy is more effective as maintenance therapy in this disease. DESIGN, SETTING, AND PARTICIPANTS This retrospective analysis over a 33-year period involved 54 children and adolescents with juvenile MG at a specialized neuromuscular clinic and electromyography laboratory at a tertiary care academic pediatric hospital. INTERVENTIONS Plasmapheresis and IVIG. MAIN OUTCOMES AND MEASURES Response to treatmentwas measured by both improvement in objective physical examination findings and the patients' reported improvement in symptoms and functional abilities. RESULTS Subjective and objective outcomes correlated well. Both PLEX and IVIG had high response rates. Of the 27 patients with generalized juvenile MG receiving PLEX, IVIG, or both treatments, 7 of 7 patients treated with PLEX alone responded, 5 of 10 patients treated with IVIG alone responded, and 9 of 10 patients who received both responded. There was a significant difference in response rates between patients who received PLEX vs IVIG (P = .04). The youngest age at which PLEX was initiated via peripheral venous access was 9 years, while the youngest child who received IVIG was 9 months old. Thymectomy was performed in 17 children, of whom 11 experienced significant postoperative improvement. CONCLUSIONS AND RELEVANCE This study provides class III evidence that PLEX and IVIG both have high response rates as maintenance therapies and are reasonable therapeutic options for juvenile MG. Plasmapheresis may have a more consistent response rate than IVIG in this setting. These findings will provide some guidance regarding the approach to therapy for juvenile MG, especially as the results differ somewhat from those of studies focusing on adult MG.
机译:重要事项重症肌无力(MG)是一种相对罕见的自身免疫性疾病。对于这种儿童疾病,血浆分离术(PLEX)与免疫球蛋白作为维持疗法的相对疗效尚不清楚。目的确定PLEX或静脉内免疫球蛋白(IVIG)疗法作为该病的维持疗法是否更有效。设计,地点和参与者这项回顾性分析历时33年,涉及一家三级护理学术儿科医院的专门神经肌肉诊所和肌电图实验室的54名患有MG的儿童和青少年。干预血浆置换和IVIG。主要结果和措施对治疗的反应是通过客观体检结果的改善和患者报告的症状和功能能力的改善来衡量的。结果主观和客观结果之间的相关性很好。 PLEX和IVIG都具有较高的响应率。在接受PLEX,IVIG或两种治疗的27例一般性MG青少年患者中,仅接受PLEX治疗的7例患者中有7例有反应,仅接受IVIG治疗的10例患者中有5例有反应,接受10例IVIG的患者中有9例有反应。接受PLEX与IVIG的患者之间的缓解率存在显着差异(P = .04)。通过外周静脉通路发起PLEX的最小年龄为9岁,而接受IVIG的最小年龄为9个月大。胸腺切除术在17例儿童中进行,其中11例术后明显好转。结论和相关性这项研究提供了III类证据,即PLEX和IVIG作为维持性疗法均具有较高的应答率,是青少年MG的合理治疗选择。在这种情况下,血浆置换可能比IVIG的应答率更一致。这些发现将为青少年MG的治疗方法提供一些指导,特别是因为结果与针对成人MG的研究有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号